HCPCS Level IIdrugActive
J9026
Inj, tarlatamab-dlle, 1 mg
BETOS: O1D
Effective: 2025-01-01
Description
Injection, tarlatamab-dlle, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Imdelltra
Manufacturer
Amgen Inc
HCPCS Dosage
1 MG
Billing Units
1.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.